Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MND Australia is the peak national body for motor neurone disease (MND) in Australia, representing the interests of people living with MND and their state-based associations. The organization is dedicated to advocacy, policy development, and the promotion of high-quality care and support services across the country. Through its research arm, MND Research Australia, it serves as a major funding body for scientific investigations into the causes, treatments, and potential cures for MND. MND Australia collaborates with international organizations, including the International Alliance of ALS/MND Associations, to align Australian research with global efforts. Their work encompasses public awareness campaigns, providing information resources, and influencing government policy to improve the lives of those affected by the disease. By fostering a national network of researchers and healthcare professionals, the organization plays a critical role in the Australian neurodegenerative disease landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MND Australia.